Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Timothy Campbell's publication output changed over time?
ScholarIQpublication output · 2005–2023
Output grew100% over the shown period — from 1 works in 2005 to 2 in 2023.
1
2
1
1
1
1
2
2
20052007201220152019202020212023
What are the most-cited papers on Timothy Campbell?
ScholarIQmost cited works
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Nikhil C. Munshi, Larry D. Anderson, Nina Shah, Deepu Madduri, Jesús G. Berdeja, Sagar Lonial, Noopur Raje, Yi Lin, David S. Siegel, Albert Oriol, Philippe Moreau, Ibrahim Yakoub‐Agha, Michel Delforge, Michèle Cavo, Hermann Einsele, Hartmut Goldschmidt, Katja Weisel, Alessandro Rambaldi, Donna Reece, Fabio Petrocca, Monica Massaro, Jamie N. Connarn, Shari M. Kaiser, Payal Patel, Liping Huang, Timothy Campbell, Kristen Hege, Jesús F. San Miguel
New England Journal of Medicine. 20212,479 CitationsOPEN ACCESS
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Noopur Raje, Jesús G. Berdeja, Yi Lin, David S. Siegel, Sundar Jagannath, Deepu Madduri, Michaela Liedtke, Jacalyn Rosenblatt, Marcela V. Maus, Ashley Turka, Lyh-Ping Lam, Richard A. Morgan, Kevin M. Friedman, Monica Massaro, Julie Wang, Greg Russotti, Zhihong Yang, Timothy Campbell, Kristen Hege, Fabio Petrocca, M. Travis Quigley, Nikhil C. Munshi, James N. Kochenderfer
New England Journal of Medicine. 20191,752 CitationsOPEN ACCESS
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
Hal E. Broxmeyer, Christie M. Orschell, D. Wade Clapp, Giao Hangoc, Scott Cooper, P. Artur Plett, W. Conrad Liles, Xiaxin Li, Barbara Graham-Evans, Timothy Campbell, Gary Calandra, Gary Bridger, David C. Dale, Edward F. Srour
S22947807. 20051,100 CitationsOPEN ACCESS
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
Mehmet Samur, Mariateresa Fulciniti, Anıl Aktaş Samur, Abdul Hamid Bazarbachi, Yu‐Tzu Tai, Rao Prabhala, A. Alonso, Adam S. Sperling, Timothy Campbell, Fabio Petrocca, Kristen Hege, Shari M. Kaiser, Hervé Avet‐Loiseau, Kenneth C. Anderson, Nikhil C. Munshi
Nature Communications. 2021417 CitationsOPEN ACCESS
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities
Koen Schepers, Timothy Campbell, Emmanuelle Passegué
S128124174. 2015415 CitationsOPEN ACCESS
Related on ScholarIQ
Bristol-Myers Squibb (United States)
Institution
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
Paper
Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma
Paper
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
Paper
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma
Paper
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities
Paper